Entry |
|
Name |
Elacytarabine (USAN/INN) |
Formula |
C27H45N3O6
|
Exact mass |
507.3308
|
Mol weight |
507.66
|
Structure |

|
Simcomp |
|
Class |
Antineoplastic
DG02018 Antimetabolite
DG01958 Nucleic acid derivative, antineoplastic
DG01439 Arabinofuranosyl type antineoplastic
|
Efficacy |
Antineoplastic, Antimetabolite |
Comment |
Elacytarabine is lipophilic 5'-elaidic acid ester of Cytarabine [DR: D00168]
arabinofuranosyl derivative
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Antineoplastic
DG02018 Antimetabolite
DG01958 Nucleic acid derivative, antineoplastic
DG01439 Arabinofuranosyl type antineoplastic
D09712 Elacytarabine
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 36
1 C8x C 35.7615 -20.6356
2 N4y N 35.7615 -22.0437
3 C8y C 36.9583 -22.7477
4 N5x N 38.2255 -22.0437
5 C8y C 38.2255 -20.6356
6 C8x C 36.9583 -19.9316
7 C1y C 34.5647 -22.7477
8 C1y C 32.7342 -24.0853
9 C1y C 34.1423 -24.0853
10 O2x O 33.4382 -21.9029
11 C1y C 32.3118 -22.7477
12 C1b C 31.1150 -22.0437
13 O7a O 29.9182 -22.7477
14 C7a C 28.7214 -22.0437
15 C1b C 27.5245 -22.7477
16 C1b C 26.2994 -22.0536
17 C1b C 25.1113 -22.7527
18 C1b C 23.8990 -22.0658
19 C1b C 22.7210 -22.7586
20 C1b C 21.5037 -22.0687
21 O6a O 28.7214 -20.6356
22 O1a O 31.9019 -25.2210
23 O1a O 34.9746 -25.2210
24 N1a N 39.4391 -19.9216
25 C1b C 20.2766 -22.7908
26 C2b C 19.0606 -22.1024
27 C2b C 17.8540 -22.8128
28 C1b C 16.6503 -22.1314
29 C1b C 15.4686 -22.8270
30 C1b C 14.2527 -22.1385
31 C1b C 13.0254 -22.8614
32 C1b C 11.8089 -22.1733
33 C1b C 10.6031 -22.8840
34 C1b C 9.3986 -22.2026
35 C1a C 8.2177 -22.8982
36 O5x O 36.9410 -24.1499
BOND 37
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 2
5 5 6 1
6 1 6 2
7 7 2 1 #Up
8 8 9 1
9 9 7 1
10 7 10 1
11 10 11 1
12 8 11 1
13 11 12 1 #Up
14 12 13 1
15 13 14 1
16 14 15 1
17 15 16 1
18 16 17 1
19 17 18 1
20 18 19 1
21 19 20 1
22 14 21 2
23 8 22 1 #Down
24 9 23 1 #Up
25 5 24 1
26 20 25 1
27 25 26 1
28 26 27 2
29 27 28 1
30 28 29 1
31 29 30 1
32 30 31 1
33 31 32 1
34 32 33 1
35 33 34 1
36 34 35 1
37 3 36 2
|